Indonesia Eyes Local Covid-19 Vaccine Mass Production by Mid-2021
The figure accounts for 176 million Indonesians who would each need two shots.
“Of course, the cost is expensive. It requires plenty of effort from all sides including researchers, academicians, and investors,” Ali said.
Ali added that it will take some time for people to receive the vaccine as it cannot be done all at once.
Read also: Daily Number of Coronavirus Cases Hits Nearly 1,400 in Indonesia
“We would need at least a year to vaccinate everyone.”
Indonesia’s Covid-19 vaccine is being developed by state-owned enterprise PT Kalbe Farma, Tbk, and South Korea’s Genexine Inc.
Chief of the National Covid-19 Task Force Wiku Adisasmito had previously shared that the first clinical trials of the Covid-19 vaccine began in South Korea in June 2020.
The second phase of clinical trials is scheduled for August 2020 in Indonesia.
(Writer: Ihsanuddin | Editor: Kristian Erdianto, Fabian Januarius Kuwado)
More Headlines
19 Javan Leopards and Black Panthers Captured on Camera in West Java
Indonesian Embassy Staff Shot Dead in Peru, Police Probe Contract Killing
President Prabowo Expresses Condolences After Driver Killed by Police Vehicle
Financial Report Reveals Billions in Losses for Indonesia’s High-Speed Rail
Indonesia’s Largest Private Bank Denies Allegations of Manipulation in 2003 Share Sale
